openPR Logo
Press release

Steady Expansion Forecast for AI In Clinical Trials Market, Projected to Reach $38.21 Billion by 2029

10-16-2025 09:14 AM CET | IT, New Media & Software

Press release from: The Business Research Company

AI In Clinical Trials

AI In Clinical Trials

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

AI In Clinical Trials Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent years, the size of the AI in clinical trials market has experienced a rapid expansion. Expectations are for the market to increase from $6.57 billion in 2024 to $9.16 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 39.5%. Factors contributing to the surge during the historic period include healthcare data accumulation, advancements in computing power, endorsement from the FDA for AI, the popularity of wearable devices, and the development of early-stage AI algorithms.

AI In Clinical Trials Market Size Forecast: What's the Projected Valuation by 2029?
The market size for AI in clinical trials is projected to witness immense growth in the coming years. The anticipated market value is $38.21 billion by 2029, with a compound annual growth rate (CAGR) of 42.9%. This growth can be linked to several factors such as the integration of real-world data, AI-enhanced patient enlistment, AI-propelled biomarker identification, and AI-aided trial design optimization, among others. The forecast period is set to experience multiple trends including collaborative learning approaches in AI, AI's application in adaptive trials, AI-assisted outcome forecasting, AI facilitated drug development and AI-enabled drug repurposing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report

What Are the Drivers Transforming the AI In Clinical Trials Market?
The surge in chronic and infectious disease instances is anticipated to invigorate the expansion of the AI in clinical trials market. Chronic diseases, which are illnesses persisting for three months or more and deteriorate over time, are often treated with drugs developed through AI in clinical trials. For instance, the Macmillan Cancer Support, a UK-based cancer charity, reported in June 2022 that the population of individuals living with cancer had reached 3 million in 2022, and is forecasted to approach nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Moreover, the UK Health Security Agency, an established UK executive agency, revealed in August 2024 that there had been 368 cases of measles in 2023 in England, indicating an almost sevenfold surge from the 53 instances documented in 2022. The two regions contributing most to these cases were the West Midlands and London, representing 44% and 33% respectively. Thus, the inflating rates of chronic and infectious diseases are fuelling the advancement of the AI in clinical trials market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11961&type=smp

What Long-Term Trends Will Define the Future of the AI In Clinical Trials Market?
The AI in clinical trials market is witnessing an accelerating trend of technological innovations. To stay competitive in the market, companies are increasingly leveraging advanced technologies. As an example, Lantern Pharma, an American clinical-stage oncology firm, unveiled its revolutionary RADR AI and ML platform in February 2023. This platform aims to transform the cost, speed, and duration of oncology drug discovery and development. The future developments of RADR will focus on integrating sophisticated AI and ML techniques to develop antibody-drug conjugates (ADCs). These are highly specific antibodies used in cancer treatment that are linked to potent anti-tumor small molecules.

Which Segments in the AI In Clinical Trials Market Offer the Most Profit Potential?
The ai in clinical trialsmarket covered in this report is segmented -

1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Technology: Machine Learning, Deep Learning, Supervised Learning, Other Technologies
4) By Application: Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications
5) By End-User: Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users

Subsegments:
1) By Software: Clinical Trial Management Systems (CTMS), Data Analytics Software, Predictive Analytics Tools, Patient Recruitment And Retention Software, Real-World Evidence Platforms
2) By Services: Consulting Services, Data Management And Analysis Services, Training And Support Services, Regulatory Compliance Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11961&type=smp

Which Firms Dominate the AI In Clinical Trials Market by Market Share and Revenue in 2025?
Major companies operating in the AI in clinical trials market include Intel, The International Business Machines Corporation (IBM), Koninklijke Philips N.V., ConcertAI, Samaa Technologies, Owkin Inc., Numerate, Neuroute, AiCure, Ardigen, Unlearn AI, PathAI, Exscentia, Aitia Infotech Pvt Ltd., Euretos, VeriSIM Life, Envisagenics, NURITAs, BioSymetrics, BioAge Labs Inc, Trials.Ai, Pharmaseal, Caylx, IQVIA

Which Regions Offer the Highest Growth Potential in the AI In Clinical Trials Market?
North America was the largest region in the AI in clinical trials market in 2024. The regions covered in the AI in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11961

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Steady Expansion Forecast for AI In Clinical Trials Market, Projected to Reach $38.21 Billion by 2029 here

News-ID: 4226753 • Views:

More Releases from The Business Research Company

Wireless and Mobile Backhaul Equipment Market on Track for Strong Growth, Estimated to Grow at 11.5% CAGR Through 2029
Wireless and Mobile Backhaul Equipment Market on Track for Strong Growth, Estima …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Wireless and Mobile Backhaul Equipment Market Through 2025? The market for wireless and mobile backhaul equipment has witnessed considerable expansion in recent times. The market size is forecasted to increase from a valuation of $41.84 billion in 2024 to $46.36 billion in
Top Market Shifts Transforming the Edge AI Hardware Market Landscape: Key Insights
Top Market Shifts Transforming the Edge AI Hardware Market Landscape: Key Insigh …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Edge AI Hardware Market Through 2025? The market size of edge ai hardware has seen significant expansion in the past few years. Its size is projected to increase from $7.74 billion in 2024 to $9.12 billion in 2025, showing a compound annual
The Impact Of Cloud And Enterprise Mobility Services On The Digital Workplace Market: Transformative Forces Shaping the Digital Workplace Market Landscape in 2025
The Impact Of Cloud And Enterprise Mobility Services On The Digital Workplace Ma …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Digital Workplace Industry Market Size Be by 2025? The market size of the digital workplace has seen swift expansion over the past few years. Projected growth indicates a rise from $49.17 billion in 2024 to $58.93 billion in 2025, boasting a hefty compound annual growth rate
Global Virtualization Security Market: Major Trends Reshaping the Future of the Industry
Global Virtualization Security Market: Major Trends Reshaping the Future of the …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Virtualization Security Industry Market Size Be by 2025? In the past few years, the size of the virtualization security market has seen a significant escalation. The market that was worth $3.18 billion in 2024 is projected to inflate to $3.68 billion in 2025, with a Compound

All 5 Releases


More Releases for Trial

Clinical Trial Investigative Site Network Market Clinical Trial Investigative Si …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trial Investigative Site Network Market - (By Therapeutic Areas (Oncology, Cardiology, CNS, Pain Management, Endocrine, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Sponsor, CRO)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic, the Global Clinical Trial Investigative Site Network Market
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period. Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the
Clinical Trial Logistics
Clinical Trial Logistics 16th to 17th May 2011, Marriott Regents Park, London, United Kingdom. It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials
Clinical Trial Logistics
Announcing SMi's 5th annual… Clinical Trial Logistics conference 16th and 17th May 2011, Central London, UK www.smi-online.co.uk/2011logistics-london6.asp It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical